Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Aimmune Therapeutics, Inc. (AIMT) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/15/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/14/2020 4 Oxtoby Andrew (Chief Commercial Officer) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Unknown transaction of 6,345 shares @ $34.5, valued at $218.9k
Disposed/sold 20,250 shares @ $34.5, valued at $698.6k
Disposed/sold 150,000 options to buy @ $21.94, valued at $3.3M
Disposed/sold 67,500 options to buy @ $23.81, valued at $1.6M
10/14/2020 4 Sheehy Douglas T. (See Remarks) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Unknown transaction of 47,450 shares @ $34.5, valued at $1.6M
Disposed/sold 36,875 shares @ $34.5, valued at $1.3M
Disposed/sold 22,361 options to buy @ $12.95, valued at $289.6k
Disposed/sold 67,500 options to buy @ $19.63, valued at $1.3M
Disposed/sold 75,000 options to buy @ $34.07, valued at $2.6M
Disposed/sold 75,000 options to buy @ $23.72, valued at $1.8M
Disposed/sold 67,500 options to buy @ $23.81, valued at $1.6M
10/14/2020 4 Dallas Jayson Donald Alexander (President and CEO) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Unknown transaction of 30,422 shares @ $34.5, valued at $1M
Disposed/sold 89,250 shares @ $34.5, valued at $3.1M
Disposed/sold 350,000 options to buy @ $30.68, valued at $10.7M
Disposed/sold 210,000 options to buy @ $23.72, valued at $5M
Disposed/sold 200,000 options to buy @ $23.81, valued at $4.8M
10/14/2020 4 MCDADE MARK (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Unknown transaction of 26,852 shares @ $34.5, valued at $926.4k
Disposed/sold 7,840 shares @ $34.5, valued at $270.5k
Disposed/sold 104,842 options to buy @ $3.02, valued at $316.6k
Disposed/sold 19,755 options to buy @ $15.4, valued at $304.2k
Disposed/sold 17,500 options to buy @ $18.26, valued at $319.6k
Disposed/sold 7,500 options to buy @ $32.79, valued at $245.9k
Disposed/sold 11,432 options to buy @ $19.9, valued at $227.5k
Disposed/sold 15,398 options to buy @ $17.11, valued at $263.5k
10/14/2020 4 Behar Gregory (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Disposed of 10,192 shares @ $0
Disposed/sold 7,840 shares @ $34.5, valued at $270.5k
Disposed/sold 39,510 options to buy @ $24.9, valued at $983.8k
Disposed/sold 17,500 options to buy @ $18.26, valued at $319.6k
Disposed/sold 7,500 options to buy @ $32.79, valued at $245.9k
Disposed/sold 11,432 options to buy @ $19.9, valued at $227.5k
Disposed/sold 15,398 options to buy @ $17.11, valued at $263.5k
10/14/2020 4 HAUMANN BRETT K (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Unknown transaction of 6,250 shares @ $34.5, valued at $215.6k
Disposed/sold 13,313 shares @ $34.5, valued at $459.3k
Disposed/sold 25,453 options to buy @ $17.11, valued at $435.5k
10/14/2020 4 Seltzer Stacey Denenberg (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Unknown transaction of 10,221 shares @ $34.5, valued at $352.6k
Disposed/sold 7,840 shares @ $34.5, valued at $270.5k
Disposed/sold 52,421 options to buy @ $6.29, valued at $329.7k
Disposed/sold 19,755 options to buy @ $15.4, valued at $304.2k
Disposed/sold 17,500 options to buy @ $18.26, valued at $319.6k
Disposed/sold 7,500 options to buy @ $32.79, valued at $245.9k
Disposed/sold 11,432 options to buy @ $19.9, valued at $227.5k
Disposed/sold 15,398 options to buy @ $17.11, valued at $263.5k
10/14/2020 4 BJERKHOLT ERIC (CFO) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Unknown transaction of 27,805 shares @ $34.5, valued at $959.3k
Disposed/sold 23,905 shares @ $34.5, valued at $824.7k
Disposed/sold 264,800 options to buy @ $19.44, valued at $5.1M
Disposed/sold 56,250 options to buy @ $34.07, valued at $1.9M
Disposed/sold 78,750 options to buy @ $23.72, valued at $1.9M
Disposed/sold 56,250 options to buy @ $23.81, valued at $1.3M
10/14/2020 4 ENRIGHT PATRICK G (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Unknown transaction of 70,561 shares @ $34.5, valued at $2.4M
Unknown transaction of 91,697 shares @ $34.5, valued at $3.2M
Disposed/sold 7,840 shares @ $34.5, valued at $270.5k
Disposed/sold 65,849 options to buy @ $0.14, valued at $9.2k
Disposed/sold 52,421 options to buy @ $6.29, valued at $329.7k
Disposed/sold 19,755 options to buy @ $15.4, valued at $304.2k
Disposed/sold 17,500 options to buy @ $18.26, valued at $319.6k
Disposed/sold 7,500 options to buy @ $32.79, valued at $245.9k
Disposed/sold 11,432 options to buy @ $19.9, valued at $227.5k
Disposed/sold 15,398 options to buy @ $17.11, valued at $263.5k
10/14/2020 4 Iwicki Mark T (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Unknown transaction of 39,567 shares @ $34.5, valued at $1.4M
Disposed/sold 7,840 shares @ $34.5, valued at $270.5k
Disposed/sold 52,421 options to buy @ $3.02, valued at $158.3k
Disposed/sold 87,368 options to buy @ $6.29, valued at $549.5k
Disposed/sold 19,755 options to buy @ $15.4, valued at $304.2k
Disposed/sold 17,500 options to buy @ $18.26, valued at $319.6k
Disposed/sold 7,500 options to buy @ $32.79, valued at $245.9k
Disposed/sold 11,432 options to buy @ $19.9, valued at $227.5k
Disposed/sold 15,398 options to buy @ $17.11, valued at $263.5k
10/14/2020 4 ADELMAN DANIEL C MD (Chief Medical Officer) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Unknown transaction of 41,464 shares @ $34.5, valued at $1.4M
Disposed/sold 22,343 shares @ $34.5, valued at $770.8k
Disposed/sold 135,068 options to buy @ $11.45, valued at $1.5M
Disposed/sold 70,000 options to buy @ $19.63, valued at $1.4M
Disposed/sold 56,250 options to buy @ $34.07, valued at $1.9M
Disposed/sold 71,250 options to buy @ $23.72, valued at $1.7M
Disposed/sold 52,500 options to buy @ $23.81, valued at $1.3M
10/14/2020 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Unknown transaction of 65,192 shares @ $34.5, valued at $2.2M
Unknown transaction of 69,894 shares @ $34.5, valued at $2.4M
Disposed/sold 7,840 shares @ $34.5, valued at $270.5k
Disposed/sold 19,755 options to buy @ $15.4, valued at $304.2k
Disposed/sold 17,500 options to buy @ $18.26, valued at $319.6k
Disposed/sold 7,500 options to buy @ $32.79, valued at $245.9k
Disposed/sold 11,432 options to buy @ $19.9, valued at $227.5k
Disposed/sold 15,398 options to buy @ $17.11, valued at $263.5k
10/05/2020 4 ADELMAN DANIEL C MD (Chief Medical Officer) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Exercised 34,932 options to buy @ $11.45, valued at $400k
10/05/2020 4 Sheehy Douglas T. (See Remarks) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Exercised 30,888 options to buy @ $12.95, valued at $400k
10/05/2020 4 BJERKHOLT ERIC (CFO) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Exercised 5,200 options to buy @ $19.44, valued at $101.1k
09/23/2020 4 ENRIGHT PATRICK G (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Disposed of 6,113,134 shares @ $0
Acquired 91,697 shares @ $0
09/16/2020 4 Sheehy Douglas T. (See Remarks) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Paid exercise price by delivering 840 shares @ $34.25, valued at $28.8k
09/16/2020 4 Oxtoby Andrew (Chief Commercial Officer) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Paid exercise price by delivering 840 shares @ $34.25, valued at $28.8k
09/16/2020 4 BJERKHOLT ERIC (CFO) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Paid exercise price by delivering 840 shares @ $34.25, valued at $28.8k
09/16/2020 4 Dallas Jayson Donald Alexander (President and CEO) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,642 shares @ $34.25, valued at $56.2k
09/16/2020 4 ADELMAN DANIEL C MD (Chief Medical Officer) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Paid exercise price by delivering 840 shares @ $34.25, valued at $28.8k
06/26/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/29/2020 4 Iwicki Mark T (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Granted 7,840 shares @ $0
Granted 15,398 options to buy @ $17.11, valued at $263.5k
05/29/2020 4 Behar Gregory (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Granted 7,840 shares @ $0
Granted 15,398 options to buy @ $17.11, valued at $263.5k
05/29/2020 4 HAUMANN BRETT K (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Granted 13,313 shares @ $0
Granted 25,453 options to buy @ $17.11, valued at $435.5k
05/29/2020 4 FALBERG KATHRYN E (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Granted 7,840 shares @ $0
Granted 15,398 options to buy @ $17.11, valued at $263.5k
05/29/2020 4 ENRIGHT PATRICK G (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Sold 7,840 shares @ $0
Granted 15,398 options to buy @ $17.11, valued at $263.5k
05/29/2020 4 MCDADE MARK (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Granted 7,840 shares @ $0
Granted 15,398 options to buy @ $17.11, valued at $263.5k
05/29/2020 4 Seltzer Stacey Denenberg (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Granted 7,840 shares @ $0
Granted 15,398 options to buy @ $17.11, valued at $263.5k
05/12/2020 4 Dallas Jayson Donald Alexander (President and CEO) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Granted 3,300 shares @ $0
05/12/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/12/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/12/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy